CONCLUSION
Overall, we identify significant racial/ethnic disparities in survival among those diagnosed with pediatric brain and CNS tumors, with Hispanic patients having the highest risk of mortality, even after accounting for stage of diagnosis, tumor grade, and SES. The observed differences in survival become more pronounced with increasing follow up time. Eliminating these disparities requires commitment towards promoting equity in healthcare delivery. Future studies aimed at delineating how differences in host and tumor genetic factors impact treatment response could help optimize treatment for patients including offering personalized cancer treatment.
CONFLICTS OF INTEREST :
There are no financial disclosures or conflicts of interest to report.